Risk Related Assistance During Stabilization In Newborns At Birth
NCT ID: NCT05023694
Last Updated: 2021-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
128 participants
OBSERVATIONAL
2016-02-29
2017-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Respiratory Dynamics During Birth Stabilization in Preterm Infants Less Than 32+6/7 Weeks Gestation
NCT02748720
LUS AT BIRTH IN INFANTS BORN BEFORE 26 WEEKS
NCT06394583
Successful Extubation and Noninvasive Ventilation in Preterm ≤ 1500g Terms
NCT02396693
Feasibility and Reliability of Synchronized Non-invasive Intermittent Positive Pressure Ventilation in Preterm Infants After Birth
NCT05399914
Physiologically Based Cord Clamping To Improve Neonatal Outcomes In Moderate And Late Preterm Newborns
NCT06280872
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The video recording programs are considered useful to monitor and detect problems during resuscitation and is believed to be useful for improving resuscitation.
HYPOTHESIS Principal: The mismatch in compliance with the guidelines for neonatal resuscitation is the main type of incident during resuscitation due to inadequate stabilization times . The cause of these incidents during resuscitation is varied and not only focuses on personal failure.
As a second hypothesis is that: the implementation of a protocol , after analysis of errors, minimizes by more than 15 % possible incidents and reduces the trip times.
EVALUATION Data collection will be made prospectively. Management during stabilization of the newborn in the delivery room with video is recorded by an independent contributor or fixed camera. Physiological parameters such as air pressure, gas flow , tidal volume , heart rate and oxygen saturation are monitored and recorded in the software monitor respiratory function and analog data FiO2
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Newborn reanimated video recordings
Newborns, requiring stabilization at birth in Delivery Room, prior authorization by verbal and written informed consent
Video recordings
In the first phase it will proceed to completion of the registration system by collecting data revivals and video recordings.
In a second phase, the video is displayed and analysis of the resuscitation performance will take place. We will identify and make a registration of incidents. At this point the observational descriptive analysis will take place.
Third phase: to develop preventive measures necessary to limit the number of incidents or to contain or minimize adverse effects resulting thereof: restructure and adapt the protocol.
Video recordings after corrective measures in adverse events
Fourth phase: Training department staff on improvements to optimize performance times protocol using simulation.
Fifth stage: final implementation of corrective measures of adverse events during the performance resuscitation.
Sixth stage: successive evaluations of impact of corrective measures. With this evaluation, it will be held another descriptive case series. With the secondary formulate hypothesis after analysis of the errors, the protocol is optimized and measured if errors are minimized: analytical observational prospective cohort study.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Video recordings
In the first phase it will proceed to completion of the registration system by collecting data revivals and video recordings.
In a second phase, the video is displayed and analysis of the resuscitation performance will take place. We will identify and make a registration of incidents. At this point the observational descriptive analysis will take place.
Third phase: to develop preventive measures necessary to limit the number of incidents or to contain or minimize adverse effects resulting thereof: restructure and adapt the protocol.
Video recordings after corrective measures in adverse events
Fourth phase: Training department staff on improvements to optimize performance times protocol using simulation.
Fifth stage: final implementation of corrective measures of adverse events during the performance resuscitation.
Sixth stage: successive evaluations of impact of corrective measures. With this evaluation, it will be held another descriptive case series. With the secondary formulate hypothesis after analysis of the errors, the protocol is optimized and measured if errors are minimized: analytical observational prospective cohort study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* no obtained informed consent
1 Minute
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Manuel Sanchez Luna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Manuel Sanchez Luna
Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gonzalo Zeballos
Role: PRINCIPAL_INVESTIGATOR
Gregorio Marañón Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
HGU Gregorio Marañón Madrid
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Neo.Segur2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.